St. Jude Children's Research Hospital has an outstanding track record of world-class research and innovation, leading to major scientific advances and ground-breaking new inventions in our mission to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Sometimes, discoveries are made that could be beneficial outside of that mission, and can represent significant opportunities for commercial development.
The Office of Technology Licensing (OTL) patents inventions with commercial potential and offers them to industry for license. Our goal is to encourage the use of our inventions for the development of products that can be used by researchers and clinicians all over the world, thus benefiting the maximum number of patients. You can explore our technology opportunities for inventions and reagents that are currently available to license.
The OTL oversees the patenting and licensing of technologies developed by the faculty and staff of St. Jude Children's Research Hospital in order to promote development of drugs, diagnostic assays and other products of benefit to the public. Additionally, the OTL is responsible for negotiating and authorizing the transfer of research materials into and out of St. Jude. Companies and research investigators from outside of St. Jude are welcome to contact the OTL regarding St. Jude's standard terms and policies for technology transfer. The OTL is the only party authorized to negotiate and finalize these agreements on behalf of St. Jude.
Below is a list of technology categories currently available at St. Jude Children's Research Hospital:
Office of Technology Licensing
St. Jude Children's Research Hospital
262 Danny Thomas Place, Mail Stop 742
Memphis, TN USA 38105-3678
Phone: (901) 595-2342
Fax: (901) 595-3148